Robb Knie
CIK: 0001609695
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Hoth Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 26, 2026RKTO
Rocket One Inc.
Award(A)DirectOptions
550K shares- - Aug 28, 2025HOTH
Hoth Therapeutics, Inc.
Tax Payment(F)Direct310.7K shares at avg. $1.21$376K - Aug 27, 2025HOTH
Hoth Therapeutics, Inc.
Award(A)Direct800K shares- - Jan 14, 2025HOTH
Hoth Therapeutics, Inc.
Award(A)DirectOptions
93K shares- - Jan 14, 2025HOTH
Hoth Therapeutics, Inc.
Award(A)DirectOptions
7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 |  RKTO Rocket One Inc. | Award(A) Options | 550,000 | - | - | Direct |
| Aug 28, 2025 | HOTH Hoth Therapeutics, Inc. | Tax Payment(F) | 310,744 | $1.21 | $376,000 | Direct |
| Aug 27, 2025 | HOTH Hoth Therapeutics, Inc. | Award(A) | 800,000 | - | - | Direct |
| Jan 14, 2025 | HOTH Hoth Therapeutics, Inc. | Award(A) Options | 93,000 | - | - | Direct |
| Jan 14, 2025 | HOTH Hoth Therapeutics, Inc. | Award(A) Options | 7,000 | - | - | Direct |
1-5 of 5 transactions
About Knie Robb
Knie Robb (SEC CIK 0001609695) files insider reports with the SEC as CEO and President of Hoth Therapeutics, Inc. (HOTH).
Signal8 holds 3 ownership filings by Knie Robb, all Form 4s, filed between Jan 15, 2025 and May 28, 2026. Those filings report 5 transactions, from Jan 14, 2025 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Knie Robb's filings is in NEW YORK, NY.
Recent filings by Knie Robb
Other insiders filing for Hoth Therapeutics, Inc. (HOTH)
- Springer Graig, Director